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RESEARCH ARTICLE
DLC1 is a direct target of activated YAP/TAZ that drives collective
migration and sprouting angiogenesis
Miesje van der Stoel1, Lilian Schimmel2, Kalim Nawaz2, Anne-Marieke van Stalborch2, Annett de Haan1,
Alexandra Klaus-Bergmann3,4, Erik T. Valent5, Duco S. Koenis1, Geerten P. van Nieuw Amerongen5,
Carlie J. de Vries1, Vivian de Waard1, Martijn Gloerich6, Jaap D. van Buul2,7 and Stephan Huveneers1,*
ABSTRACT
Endothelial YAP/TAZ (YAP is also known as YAP1, and TAZ as
WWTR1) signaling is crucial for sprouting angiogenesis and vascular
homeostasis. However, the underlying molecular mechanisms that
explain how YAP/TAZ control the vasculature remain unclear. This
study reveals that the focal adhesion protein deleted-in-liver-cancer 1
(DLC1) is a direct transcriptional target of the activated YAP/TAZ–
TEAD complex. We find that substrate stiffening and VEGF stimuli
promote expression of DLC1 in endothelial cells. In turn, DLC1
expression levels are YAP and TAZ dependent, and constitutive
activation of YAP is sufficient to drive DLC1 expression. DLC1 is
needed to limit F-actin fiber formation, integrin-based focal adhesion
lifetime and integrin-mediated traction forces. Depletion of endothelial
DLC1 strongly perturbs cell polarization in directed collective migration
and inhibits the formation of angiogenic sprouts. Importantly, ectopic
expression of DLC1 is sufficient to restore migration and angiogenic
sprouting inYAP-depleted cells. Together, these findings point towards
a crucial and prominent role for DLC1 in YAP/TAZ-driven endothelial
adhesion remodeling and collective migration during angiogenesis.
This article has an associated First Person interview with the first
author of the paper.
KEY WORDS: Mechanotransduction, Endothelium, Adhesion,
Integrin, YAP, Angiogenesis
INTRODUCTION
The formation of new blood and lymphatic vessels through
angiogenesis is essential for development and vital for tissue
regeneration and tumorigenesis (Gomez-Salinero and Rafii, 2018;
Potente et al., 2011). The luminal side of the vasculature is covered
by a well-organized layer of endothelial cells. Angiogenesis is
driven by endothelial cell proliferation and migration, during which
the endothelial cells coordinate their movements collectively
through remodeling of interactions with the vascular
microenvironment and contacts between the endothelial cells
(Betz et al., 2016; Szymborska and Gerhardt, 2018).
The yes-associated protein (YAP, also known as YAP1) and
transcriptional co-activator with PDZ-binding motif (TAZ or
WWTR1) proteins are key molecular switches that shuttle between
the cytoplasm and nucleus to control proliferation and migration
(Panciera et al., 2017). Several studies have demonstrated the
importance of YAP/TAZ for angiogenesis and vascular homeostasis
(Choi et al., 2015; Nakajima et al., 2017; Wang et al., 2016a, 2017;
Neto et al., 2018). Mechanical cues, such as extracellular matrix
(ECM) stiffness and shear stress, control the activity of YAP/TAZ
(Dupont, 2016) and are important tissue properties that guide
angiogenesis (Dorland and Huveneers, 2017; Choi et al., 2015;
Nakajima et al., 2017; Wang et al., 2016a, 2017; Neto et al., 2018).
In addition, angiogenic signaling through vascular endothelial growth
factor (VEGF) promotes activation of YAP/TAZ and a migratory
transcriptional program to support developmental angiogenesis
(Wang et al., 2017). YAP and TAZ activation is further regulated
by Rho GTPase signaling and cytoskeletal contractility (Dupont
et al., 2011; Elosegui-Artola et al., 2017).
Inactive YAP and TAZ are localized in the cytoplasm, whereas
active YAP and TAZ (i.e. upon ECM stiffening, disturbed flow or
sparse cell densities) translocate to the nucleus (Dupont et al.,
2011). Nuclear YAP/TAZ act as co-activators of TEA domain
family members (TEAD) transcription factors to promote vascular
development (Vassilev et al., 2001; Astone et al., 2018). Recently, it
was shown that YAP/TAZ activation is needed to provide
transcriptional feedback for collective migration of endothelial
cells (Mason et al., 2019). Strikingly, the transcriptional target(s) of
YAP/TAZ that are responsible for endothelial migration in
angiogenesis remain to be identified.
We previously observed that deleted-in-liver-cancer 1 (DLC1, also
known as STARD12 or ARHGAP7) expression is high in endothelial
cells on stiff substrates (Schimmel et al., 2018), pointing towards a
putative downstream role for DLC1 in YAP/TAZ signaling. DLC1 is
crucial for embryonic development and its depletion in mice leads to
severe defects of various organs at embryonic day (E)10.5 (Durkin
et al., 2005). DLC1 is an endothelial-enriched GTPase-activating
protein (GAP) that inactivates Rho GTPases (van Buul et al., 2014).
In addition, DLC1 has a serine-rich region that contains binding
motifs for components of integrin-based focal adhesions (Barras and
Widmann, 2014; Kim et al., 2009). Focal adhesions are crucial
structures for mechanotransduction and migration, as they connect
cells to the ECM and mechanically couple the contractile actin
cytoskeleton to the extracellular microenvironment (Geiger et al.,
2001; Gardel et al., 2010; Grashoff et al., 2010).Received 1 October 2019; Accepted 6 January 2020
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In this study, we identify DLC1 as a novel transcriptional target of
the activated YAP/TAZ–TEAD complex. Expression of DLC1 is
needed for integrin-based focal adhesion disassembly, cell
polarization, collective cell migration and angiogenic sprouting.
We further demonstrate that ectopic expression of DLC1 in YAP-
depleted endothelial cells restores their migration and angiogenic
sprouting capacity. In conclusion, we demonstrate that DLC1 is a
crucial transcriptional target of YAP/TAZ in the endothelium.
These findings place DLC1 as a key player in YAP/TAZ signaling
and likely has wider implications for YAP/TAZ-driven flow sensing
and the development of stiffness-related vascular diseases.
RESULTS
DLC1 is a transcriptional target of YAP/TAZ and TEAD
We recently showed that DLC1 protein expression is high within
stiff microenvironments of the vasculature (Schimmel et al., 2018).
To investigate if varying substrate stiffness directly controls DLC1
expression, primary human umbilical vein endothelial cells
(HUVECs) were cultured on fibronectin-coated 2 kPa (soft),
50 kPa (intermediate stiffness) and plastic (stiff ) substrates.
Western blot analysis of HUVEC lysates demonstrated elevated
DLC1 protein levels on stiffer substrates (Fig. 1A). To study
whether DLC1 upregulation in stiff microenvironments occurs
through transcriptional upregulation we performed quantitative
PCR (qPCR) on RNA isolations from HUVECs. These experiments
showed that mRNA levels of DLC1 are increased on stiff substrates
(Fig. 1B). To investigate how DLC1 transcription is controlled by
stiffness, we explored the promoter region of the DLC1 gene. We
found a TEAD-binding motif (CATTCCA) close to the
transcriptional start site of the predominant DLC1 transcript
variant expressed in endothelial cells (transcript variant 2,
encoding for a 123 kDa protein). Analysis of publicly available
TEAD1 chromatin immunoprecipitation sequencing data sets
showed that TEAD1 binds this particular motif in a variety of
different cell types (Fig. 1C; Fig. S1). To study whether the TEAD-
binding motif in the promoter region of DLC1 transcript variant 2
regulates promoter activity, wild-type or a TEAD binding motif-
mutated variant of the promoter region of DLC1 (−418 to +319 bp)
was fused to a luciferase reporter gene in a transient expression
plasmid. Since transfections were inefficient in the primary
HUVECs, luciferase activity was monitored in lysates of
transfected HEK cells cultured on plastic (stiff ) substrates, which
showed that mutating the TEAD motif perturbed transcriptional
activation of the DLC1 promoter (Fig. 1D). Because YAP and TAZ
act as co-factors for the TEAD family of transcription factors
(Vassilev et al., 2001; Astone et al., 2018), we next investigated
whether YAP or TAZ are responsible for stiffness-induced DLC1
expression in endothelial cells. We performed short hairpin RNA
(shRNA)-based knockdowns of YAP and TAZ in HUVECs
cultured on plastic (stiff ) substrates. Western blot analysis showed
a strong reduction in the expression of DLC1 upon knockdown of
YAP or TAZ (Fig. 1E,F), as well as the known YAP/TAZ–TEAD
target connective tissue growth factor (CTGF, also known as CCN2)
(Zhao et al., 2008).
To establish whether activation of YAP/TAZ through other
upstream cues might control DLC1 expression levels, serum and
growth factor-starved HUVECs were treated with VEGF for 2 h.
Indeed, the VEGF treatments readily activated YAP, as analyzed by
reduced phosphorylation of its serine 127 as reported previously
(Wang et al., 2017), and upregulated expression levels of DLC1
(Fig. 1G). Next, a constitutive nuclear YAP-5SAmutant that cannot
be inactivated by the LATS1 and LATS2 (LATS1/2) kinases of the
Hippo pathway (Zhao et al., 2007), was expressed in HUVECs.
Expression of YAP-5SA strongly upregulated DLC1 and CTGF
expression in HUVECs cultured on plastic substrates (Fig. 1H). To
investigate whether the constitutively active YAP-induced
expression of DLC1 depends on substrate stiffness, control and
YAP-5SA-expressing HUVECs were cultured on 2 kPa substrates.
Western blot analysis demonstrated that YAP-5SA efficiently
promoted DLC1 expression even on soft substrates (Fig. 1I).
Overall, these results demonstrate that DLC1 is a transcriptional
target of YAP/TAZ and TEAD in the endothelium, and that YAP
activation is sufficient to drive DLC1 expression.
DLC1 controls endothelial focal adhesion turnover and
traction forces
To investigate the role of DLC1 downstream of YAP/TAZ in the
endothelium, we silenced DLC1 expression through shRNAs.
Three of the five tested shRNA plasmids induced efficient
knockdown of DLC1 protein levels in HUVECs (Fig. 2A) and
shDLC1 plasmids #1063 and/or #1064 were used for follow-up
experiments. DLC1 might function at cadherin-based cell–cell
junctions and integrin-based focal adhesions (Tripathi et al., 2012;
Zacharchenko et al., 2016; Qian et al., 2007). DLC1 knockdown
resulted in the formation of prominent basal F-actin fibers in
endothelial cells, while the cells maintained their VE-cadherin-
based cell–cell junctions (Fig. 2B). As YAP/TAZ are required for
VE-cadherin dynamics and cell–cell junction formation in the
vasculature (Neto et al., 2018), we first investigated the role of
DLC1 in endothelial barrier function by performing electric cell–
substrate impedance sensing (ECIS). Upon knockdown of DLC1,
no significant changes were detected in endothelial barrier
formation and maintenance of the barrier in time (Fig. 2C). Since
DLC1 is a GAP for Rho GTPases (Kim et al., 2009), we next
compared the GTP-loading of RhoA in lysates of shControl- and
shDLC1-expressing HUVECs by means of G-LISA. We detected
no differences in either basal or thrombin-stimulated RhoA activity
levels between shControl and shDLC1 cells (Fig. 2D). These data
indicate that endothelial DLC1 is not required for the formation of
endothelial cell–cell junctions, barrier function or RhoA activation.
Lentiviral expression of an N-terminal GFP-tagged DLC1 (Qian
et al., 2007) showed that DLC1 is recruited to focal adhesions in
HUVECs (Fig. 2E). Next, we investigated the role of DLC1 at
endothelial integrin-based adhesions by immunofluorescence
staining for paxillin in shControl- and shDLC1-expressing
HUVECs. These experiments showed that depletion of DLC1
strongly increased the number of focal adhesions that were
connected to prominent F-actin fibers (Fig. 2F). Integrin-based
focal adhesions are highly dynamic structures, and are constantly
being formed and disassembled (Möhl et al., 2012; Geiger et al.,
2009; Gardel et al., 2010). To decipher the mechanism underlying
the remodeling of focal adhesions mediated by DLC1, we
performed live imaging using total internal reflection fluorescence
microscopy (TIRF) of shControl and shDLC1 HUVECs expressing
mCherry-tagged paxillin. Consistent with our above findings, the
TIRF imaging showed that DLC1-depleted HUVECs contained
more focal adhesions (Fig. 2G; Movie 1; note only ∼10–20% of the
cell population in the monolayer is paxillin–mCherry positive).
Overall, the change in adhesion turnover in the absence of DLC1
resulted in a striking stabilization of the focal adhesions (Fig. 2G,
pseudocolored focal adhesions in right panels). Quantitative
analysis using established focal adhesion-tracking software
(Berginski and Gomez, 2013) showed an increase in focal
adhesion lifetime, which corresponded with a decrease in focal
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adhesion disassembly rates, while assembly rates remained
comparable (Fig. 2H). To investigate the functional consequences
of depletion of DLC1 for force transduction from cells to the
ECM, traction force microscopy (TFM) was performed using
shControl- and shDLC1-expressing HUVECs. These experiments
demonstrated that depletion of DLC1 promoted endothelial traction
forces throughout the monolayer, and strongly raised the root mean
square of exerted traction forces (Fig. 2I). Thus, DLC1 expression is
Fig. 1. See next page for legend.
3

















driven by substrate stiffness, and in turn, expression of DLC1
controls force transduction at the cell–ECM interface. Together, the
data show that DLC1 is needed for efficient turnover of endothelial
focal adhesions and traction forces.
Endothelial DLC1 controls cell orientation and directed
migration
In cell collectives, YAP/TAZ translocate to the nuclei of leader cells
to regulate endothelial cell migration (Lin et al., 2017; Yu and Guan,
2013; Zhang et al., 2015; Mason et al., 2019; Neto et al., 2018) (see
also Fig. S3). We next examined whether endothelial DLC1 is
involved in collective cell migration. Knockdown of DLC1 strongly
inhibited endothelial migration in scratch wound assays (Fig. 3A–C;
Movie 2), supporting previous findings for a role of DLC1 in
migration of prostate epithelial cells (Shih et al., 2012). Within 12 h,
control monolayers closed on average 88.89% of the wound area,
while DLC1 knockdown inhibited scratch wound closure (41.66%
and 67.16% for an shRNA targeting the 3′ UTR of DLC1 mRNA
and clone #1063 respectively; Fig. 3B,C). No changes in cell
proliferation were observed between the conditions (Fig. 3D),
indicating that the delay in wound healing was due to migration
defects. To investigate how DLC1 controls cell dynamics, we
performed tracking of individual endothelial cells within the
confluent monolayers in time-lapse experiments. Whereas control
cells migrated collectively in a persistent fashion in the direction of
wound closure, DLC1-depleted cells lost their capability for
directional migration (Fig. 3E; Movie 2). These data demonstrate
that DLC1 coordinates collective cell migration.
Cell polarization is needed for persistent migration, and is
characterized by the orientation of the Golgi in front of the nucleus
(Kupfer et al., 1982; Bisel et al., 2013). To study whether DLC1
controls cell polarization during migration, shControl- and
shDLC1-expressing endothelial monolayers were analyzed 6 h
after the initiation of scratch wound migration. Golgi orientation
was determined in the first three leader cell rows in
immunostainings for GM130 (also known as GOLGA2, a Golgi
marker). In control HUVECs, 60% of the cells oriented their Golgi
in the direction of migration, whereas only 23% to 37% of DLC1-
depleted cells were polarized (Fig. 3F). To decipher the importance
of DLC1 in the establishment of polarized leader cells, we
performed a competition scratch assay. We generated mosaic
endothelial monolayers in which half of the population of HUVECs
expressed shControl with a RFP tag or HUVECs expressing the
shDLC1 3′UTR and GFP. Next, scratch assays were performed and
the identity of the leader cells during collective migration was
determined at t=0 and t=12 h after scratching. The experiments
demonstrated that the leading front is predominantly formed by cells
that express DLC1, whereas DLC1-depleted cells failed to lead
during the collective cell migration process (Fig. 3G; Movie 3). To
investigate whether the failure of DLC1 knockdown cells to lead
collective migration relates to differences in focal adhesion
turnover, we investigated the alignment of focal adhesions in
leader cells 6 h after the onset of migration. Immunostainings for
vinculin, a marker of focal adhesions, showed that, in the absence of
DLC1, the focal adhesions aligned more among each other than in
control cells, but the aligned focal adhesions oriented
perpendicularly (>90° dominant angle) to the direction of scratch
wound closure (Fig. 3H). Overall, these results clearly show that
DLC1 is needed for endothelial cell polarization and focal adhesion
organization during collective cell migration.
DLC1 is required for sprouting angiogenesis
Directional migration of endothelial cells is essential for sprouting
angiogenesis (Lamalice et al., 2007; Eilken and Adams, 2010;
Franco et al., 2015). Moreover, the sensing of ECM stiffness and
exertion of tensional forces occurs through endothelial integrin-
based adhesions and directs the formation of angiogenic sprouts
(Fischer et al., 2019; Korff and Augustin, 1999). To establish
whether DLC1 plays a role in angiogenic sprouting, shControl and
shDLC1 HUVECs were cultured in spheroids and placed in 3D
collagen matrices to assess sprouting capacity as described
previously (Heiss et al., 2015; Martin et al., 2018). Subsequently,
sprouting was induced by treatment with VEGF. Visualization of
sprout formation after 16 h, showed a decrease in cumulative length
and the number of sprouts after depletion of DLC1 (Fig. 4A).
Fig. 1. DLC1 is a transcriptional target of YAP/TAZ and TEAD.
(A) Representative western blot analysis of DLC1 and α-tubulin (loading
control) in total lysates of HUVECs cultured on fibronectin-coated 2 kPa or
50 kPa hydrogels, or plastic. Graph shows themean±s.e.m. protein expression
levels. Signal has been corrected for background and relative to expression in
HUVECs on plastic. Data from four independent experiments. *P<0.05;
**P<0.01; ***P<0.001 (one-way ANOVA and Dunnett’s post-test). (B) qPCR
analysis of DLC1 mRNA isolated from HUVECs cultured on fibronectin-coated
2 kPa or 50 kPa hydrogels, or plastic. Graph shows the mean±s.e.m. gene
expression levels. Values are normalized to expression levels for the
housekeeping gene RPLP0, and are presented relative to mRNA expression
levels in HUVECs on plastic. Data from three independent experiments.
*P<0.05; **P<0.01; n.s., not significant (one-way ANOVA and Dunnett’s post-
test). (C) Schematics of UCSC genome browser results at position
chr8:13,074,715-13,142,890 of the human genome (GRCh38/hg38)
displaying the genomic location of DLC1 transcript variants 1 (NP872584.2),
2 (NP.006085.2) and 5 (NP.001303597.1) and the presence of a TEADmotif at
the transcriptional start site of DLC1 transcript variant 2. Plotted are the results
from publicly available GEO TEAD1 ChIP-Seq data (Table S1) from various
cell types. The data showa binding peak of TEAD1 at the transcription start site
(TSS) of DLC1 isoform 2. See Fig. S1 for more details, including histone
modification and DNase hypersensitivity profiles of the promoter region in
HUVECs. (D) Graph shows themean±s.e.m. relative promoter activity of DLC1
in lysates of HEK cells transfected with the wild-type (WT) human DLC1
promoter region (from the−418 to +319 bp position relative to the TSS of DLC1
isoform 2) fused to a firefly luciferase reporter or a DLC1 promoter luciferase
reporter in which the TEAD-binding motif was mutated from CATTCCA to
AGACTAT. Firefly luciferase activities of the TEAD mutated promoter were
corrected for co-transfected Renilla luciferase activity and normalized to WT
promoter activity. Data are from four independent experiments. *P<0.05
(paired Student’s t-test). (E,F) Representative western blot analysis of DLC1 in
total lysates of HUVECs transduced with shControl, shYAP (E) or shTAZ (F).
Graph shows the mean±s.e.m. protein expression level signal corrected for
background and normalized to expression in shControl-transduced HUVECs.
Data from three independent experiments. *P<0.05, **P<0.01 (paired
Student’s t-test). (G) Representative western blot analysis of DLC1, YAP
phosphorylated at serine 127 (pYAPS127), YAP1 and β-actin (loading control)
in total cell lysate samples of starved non-stimulated HUVECs (–) or starved
HUVECs stimulated with 1 mg/ml VEGF for 2 h. Graph shows the mean
±s.e.m. protein expression level signal corrected for background and
normalized to expression in non-transduced HUVECs. Data from six
independent experiments. *P<0.05, **P<0.01 (paired Student’s t-test).
(H) Representative western blot analysis of DLC1, YAP1, Myc, CTGF and
β-actin (loading control) in total lysates of non-transduced HUVECs (WT) and
HUVECs transduced with Myc-tagged human YAP-5SA. Graph shows the
mean±s.e.m. protein expression level signal corrected for background and
normalized to expression in non-transduced HUVECs. Data from four
independent experiments. *P<0.05 (paired Student’s t-test). (I) Representative
western blot analysis of DLC1, YAP1, Myc and β-actin (loading control) in
total lysates of non-transduced HUVECs (WT) and HUVECs transduced with
Myc-tagged human YAP-5SA cultured on 2 kPa hydrogels. Graph shows the
mean±s.e.m. protein expression level signal corrected for background and
normalized to expression in non-transduced HUVECs. Data from three
independent experiments. *P<0.05 (paired Student’s t-test). Scans of
whole western blots are depicted in Fig. S2.
4

















Fig. 2. See next page for legend.
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Moreover, overexpression of GFP–DLC1 efficiently promoted
sprout formation compared to GFP-transduced control HUVECs
(Fig. 4B). These data indicate that expression levels of DLC1
determine angiogenic sprouting efficiency. To verify the
contribution of DLC1 in sprouting angiogenesis, we first depleted
endogenous DLC1 by mean of shRNAs targeting the 3′ UTR of the
mRNA. Subsequently, GFP or GFP–DLC1, which are not targeted
by the shRNAs, were expressed. Restoring expression of DLC1
efficiently rescued endothelial sprouting capacity (Fig. 4C).
Western blot analysis confirmed the knockdown and expression
of the GFP-tagged DLC1 (Fig. 4D). Overall, the data indicate that
endothelial DLC1 expression levels tightly control sprouting
angiogenesis.
DLC1 rescues the migration and sprouting defects in
YAP-depleted endothelial cells
Endothelial YAP/TAZ activation drives angiogenesis by controlling
endothelial collective migration and vessel remodeling (Neto et al.,
2018; Kim et al., 2017). The transcriptional targets of YAP/TAZ
that are responsible for this task remain unknown. Since DLC1 is
needed for collective migration and angiogenic sprouting, we next
assessed the contribution of DLC1 as downstream target of YAP.
First, YAP expression was silenced using shRNAs. The knockdown
of YAP in HUVECs, which is accompanied by a downregulation of
DLC1 expression, inhibited scratch wound migration (Figs 5A–C
and 1E), confirming previous findings (Neto et al., 2018).
Immunofluorescence imaging further revealed that the defective
scratch wound migration of YAP-depleted HUVECs is
accompanied by the formation of perpendicularly oriented focal
adhesions and actin stress fibers in cells at the leading edge
(Fig. 5D), reminiscent of the morphology of DLC1-depleted
HUVECs in scratch wound assays. To investigate the contribution
of DLC1 as target of YAP in focal adhesion remodeling during
collective migration, DLC1 protein levels were restored in shYAP
HUVECs by ectopic expression of GFP–DLC1 (Fig. 5C). Ectopic
expression of DLC1 in shYAP HUVECs, induced proper alignment
of focal adhesions and the actin cytoskeleton of cells at the leading
edge, and partially rescued the collective cell migration defects of
YAP-depleted cells (Fig. 5A–D). Next, to address the contribution
of DLC1 in YAP-dependent sprouting angiogenesis, the cells were
analyzed for their sprouting capacity. Intriguingly, restoring DLC1
levels by ectopic expression of DLC1 fully rescued the sprouting
defects of YAP-depleted HUVECs (Fig. 5E). Taken together, these
findings point towards a crucial and prominent role for DLC1 in
YAP/TAZ-driven endothelial adhesion remodeling and collective
migration during angiogenesis.
DISCUSSION
The nuclear translocation of YAP/TAZ during stiffness and flow
sensing tightly controls cell–ECM interactions, yet the downstream
targets of YAP/TAZ that are responsible for such mechanoresponses
still remain unclear (Totaro et al., 2018). Our study reveals that the
focal adhesion protein DLC1 is a direct transcriptional target of YAP/
TAZ and TEAD, and is crucial for YAP-driven collective cell
migration and sprouting angiogenesis by endothelial cells. These
findings implicate DLC1 in related YAP/TAZ-driven
mechanotransduction processes, such as flow sensing, contact
inhibition and the development of stiffness-related vascular disease.
DLC1 and the regulation of endothelial adhesion dynamics
YAP/TAZ are important mechanotransducers that translocate to the
nucleus upon cell–ECM adhesion-induced actomyosin tension
(Dupont et al., 2011). In turn, YAP/TAZ activation has been shown
to control focal adhesions in various cell types (Nardone et al., 2017).
Endothelial focal adhesions have recently been shown to provide
feedback signals to YAP/TAZ activity to limit adhesion maturation
for cell orientation and persistent migration (Mason et al., 2019).
Intriguingly, our data now demonstrate that DLC1, following
activation of YAP/TAZ, restricts focal adhesion lifetime, confines
integrin-based traction forces and thereby promotes cell polarization
during directedmigration. These findings suggest that upregulation of
DLC1 expression upon YAP/TAZ activation provides the feedback
signals for optimal adhesion remodeling and force transduction.
It is still uncertain how DLC1 controls the turnover of focal
adhesions and endothelial dynamics. Adhesion turnover is steered
by spatiotemporal activation of Rho GTPases and subsequent
cytoskeletal remodeling (Webb et al., 2002; Etienne-Manneville
and Hall, 2002). DLC1 is widely known as a Rho GAP protein that
acts to inhibit GTP-loading of Rho GTPases (Wong et al., 2003;
Healy et al., 2008). The GAP activity of DLC1 contributes to the
tumor-suppressive functions of DLC1 (Healy et al., 2008; Ko et al.,
2013). However, we find no major differences in RhoA activation
upon depletion of DLC1, pointing towards an alternative function of
DLC1 in endothelial adhesion remodeling. In epithelial cells DLC1
Fig. 2. DLC1 controls endothelial focal adhesion turnover and traction
forces. (A) Representative western blot analysis of DLC1 and β-actin (loading
control) in total lysates of HUVECs transduced with different shDLC1 clones
(#1067, #1066, #1065, #1064 and #1063). Graph shows the mean. DLC1
protein expression level signal corrected for background and normalized to
expression in shControl-transduced HUVECs. Data from two independent
experiments. *P<0.05; **P<0.01; n.s., not significant (paired Student’s t-test).
(B) Widefield immunofluorescence images of HUVECs transduced with
shControl or shDLC1 (pool of #1063 and #1064) and stained for VE-cadherin
(green) and F-actin (red). (C) Line graph shows themean±s.d. transendothelial
impedance measured at 4000 Hz across barrier-forming endothelial cells
transduced with shControl or shDLC1 (pool of #1063 and #1064) plated on
fibronectin-coated 8W10E ECIS arrays. Representative data are from two
independent experiments and an average of six wells per condition. (D) Box-
plot showing quantification of RhoA activity in G-LISA assays in lysates of
shControl and shDLC1-transduced HUVECs, with or without thrombin
stimulation. Whiskers show the range. Data are from four independent
experiments. A.U., arbitrary units. n.s., not significant (two-tailed unpaired
Student’s t-test). (E) Representative widefield immunofluorescence images of
HUVECs transduced with GFP–DLC1 stained for Paxillin pY118 (red) and
F-actin (blue). (F) Widefield immunofluorescence images of shControl- and
shDLC1-transduced HUVECs stained for paxillin pY118 (green), F-actin (blue)
and VE-cadherin (red). Box-plot showing quantification of manually counted
number of focal adhesions (FAs) per µm2 of shControl- and shDLC1-
transduced HUVECs. Whiskers show the range. Data are from two
independent experiments, shControl (42 cells from 12 images) and shDLC1
(46 cells from 19 images). **P<0.01 (two-tailed unpaired Student’s t-test).
(G) Left images are stills from time-lapse TIRF microscopy at t=0 of HUVECs
transduced with shControl or shDLC1, and paxillin–mCherry. Heat map in the
right panels shows the corresponding focal adhesion dynamics over 30 min in
a unique color per time frame. Note the stability of focal adhesions in shDLC1
HUVECs. See corresponding Movie 1 for the ∼2.5 h time-lapse recording.
(H) Bar graphs showing quantification of focal adhesion lifetime, assembly and
disassembly rates based on TIRF time-lapse experiments with paxillin–
mCherry- expressing HUVECs. Error bars are s.e.m. Data are from two
independent experiments; shControl (six movies, more than 4000 tracked focal
adhesions) and shDLC1 (eight movies, more than 6000 tracked focal
adhesions). Focal adhesion tracking was performed using the focal adhesion
analysis webserver (Berginski and Gomez, 2013). **P<0.01; n.s., not
significant (two-tailed unpaired Student’s t-test). (I) DIC images and cell–
substrate traction force maps of HUVECs transduced with shControl or
shDLC1. Box-plot showing the median (and upper and lower quartiles) of
measured RMS traction forces of shControl (12 image fields) and shDLC1 (18
image fields) endothelial cells. Whiskers show the range. Data are from three
independent experiments. ***P<0.001 (two-tailed unpaired Student’s t-test).
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Fig. 3. See next page for legend.
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is involved in migration through a GAP-independent mechanism
(Shih et al., 2012), and in HeLa cells the recruitment of DLC1 to
focal adhesions is needed for its pro-migratory function
(Kawai et al., 2009). DLC1 has been shown to interact with the
integrin-related talin and tensin proteins, as well as focal
adhesion kinase (FAK, also known as PTK2) (Qian et al., 2007;
Liao and Lo, 2008; Li et al., 2011; Zacharchenko et al., 2016).
Interestingly, tension-induced conformational unfolding of talin, a
key mechanosensor for integrins, inhibits its interaction with DLC1
and prevents downstream inhibition of myosin phosphorylation
(Haining et al., 2018). Thus, interaction between DLC1 and talin
proteins might regulate myosin-driven turnover of focal adhesions
to favor migration. The finding that focal adhesions align more in
the absence of DLC1 during collective migration correlates with the
observation that DLC1 knockdown resulted in the formation of
prominent aligned basal F-actin fibers that terminate at the focal
adhesions (Figs 2B and 3H). The increased focal adhesion
alignment fits with the concept that the presence of basal F-actin
stress fibers is indicative of focal adhesion maturation and force
transmission to the ECM (Soiné et al., 2015), which is supported by
the observations that a longer lifetime of the focal adhesions and
increased traction forces were detected in DLC1-depleted cells
(Fig. 2H,I).
Of note, in fibroblasts and various cancer cell types, DLC1 seems
to have an opposing role in cell migration (Heering et al., 2009;
Barras and Widmann, 2014; Kaushik et al., 2014), which might
relate to differences in YAP/TAZ mechanosensing and indicates
that the function of DLC1 is highly dependent on the cellular
microenvironment. Within blood vessels, mechanotransduction
through integrins predominantly occurs in arterial endothelium
(Van Geemen et al., 2014; Di Russo et al., 2017), suggesting that the
regulation of focal adhesions by DLC1 could be of particular
importance in arteries.
The role of YAP/TAZ and DLC1 in angiogenesis
YAP/TAZ signaling serves prominent roles in vascular biology and
angiogenesis (Choi et al., 2015; Nakajima et al., 2017; Wang et al.,
2016a, 2017; Neto et al., 2018). YAP/TAZ is regulated by ECM
rigidity, (blood) flow and cell density, mechanical cues that also
influence angiogenesis (Zhao et al., 2007; Aragona et al., 2013;
Wang et al., 2016a,b; Boerckel et al., 2011). In addition, the
angiogenesis process is supported by mechanical stretch- and
VEGF-mediated activation of YAP/TAZ (Neto et al., 2018; Wang
et al., 2017). Our experiments using YAP-5SA show that
constitutive YAP activation is sufficient to drive DLC1 expression
irrespective of the stiffness of the substrate. The data suggest that
constitutive activation of YAP overrules the substrate-mediated
regulation of DLC1 expression. Interestingly, microarray analysis of
HUVECs expressing constitutive nuclear YAP and TAZ mutants,
which induce hypersprouting in angiogenesis, also revealed that
there was an upregulation of DLC1 expression among the regulation
of other transcriptional programs (Neto et al., 2018). We now reveal
that DLC1 is needed for VEGF-induced sprouting, and that ectopic
DLC1 expression is sufficient to restore migration and sprouting in
YAP-depleted endothelial cells. Of note, previous studies have
demonstrated that TAZ serves an even stronger role during
collective migration (Neto et al., 2018). Whether DLC1 is also
capable of restoring collective migration during sprouting in TAZ-
deficient endothelial cells remains to be examined in future studies.
DLC1 and the related protein DLC2 (also known as STARD13)
have been shown to contribute to experimentally induced
angiogenesis in vivo (Shih et al., 2017; Lin et al., 2010).
Moreover, DLC1 was described to regulate contact inhibition of
growth in endothelial cells (Sánchez-Martín et al., 2018). This fits
with a model in which DLC1 expression levels are tightly controlled
for endothelial rearrangements during angiogenesis. The adherens
junction receptor VE-cadherin, an endothelial-specific cadherin that
safeguards vascular integrity and steers endothelial dynamics
(Carmeliet et al., 1999; Bentley et al., 2014), sequesters YAP at
stabilized endothelial cell–cell junctions to prevent its activation
(Giampietro et al., 2015). Possibly, the inhibition of YAP/TAZ
nuclear translocation by VE-cadherin contributes to stabilization of
Fig. 3. DLC1 is required for cell orientation and directional migration.
(A) Representative phase-contrast images of HUVECs transduced with
shControl, shDLC1 3′UTR or shDLC1 #1063, in a scratch-wound assay (t=0,
t=4, t=8 and t=12 h after scratch). The yellow lines highlight the unclosed
wound area. See corresponding Movie 2 for the ∼16 h time-lapse recording.
(B) Graph showing the mean±s.e.m. percentage of wound closure of HUVECs
transduced with shControl, shDLC1 3′UTR or shDLC1 #1063 at three time
points during scratch-wound assay. Data are from four independent
experiments; shControl (22 movies), shDLC1 3′UTR (14 movies) and shDLC1
#1063 (18 movies). *P<0.05, ***P<0.001 (two-way ANOVA and Tukey’s
multiple comparison test). (C) Representative western blot analysis of DLC1
and α-tubulin (loading control) in total lysates of HUVECs transduced with
shControl, shDLC1 3′UTR or shDLC1 #1063. Graph shows mean±s.e.m.
DLC1 protein expression level signal corrected for background and normalized
to expression in shControl-transduced HUVECs. Data from four independent
experiments. ***P<0.001 (paired Student’s t-test). Scans of whole western
blots are depicted in Fig. S4. (D) Box-plot showing the median (and upper and
lower quartiles) for the proliferation ratio of the shControl, shDLC1 3′UTR,
shDLC1 #1063 HUVECs corresponding to the scratch assays in B. The
proliferation ratio was manually determined by counting cell numbers at
regions of interest (ROIs) within the endothelial monolayers before and after
12 h scratch wound migration. n.s., not significant (one-way ANOVA with
Dunnett’s multiple comparison test). (E) Phase-contrast images of scratch
wound assays overlaid with single-cell tracking analysis for 8 h as determined
using theChemotaxis Tool in ImageJ. Box-plot showing themedian (and upper
and lower quartiles) velocity and directionality of shControl, shDLC1 3′UTR or
shDLC1 #1063-transduced HUVECs.Whiskers show the range. Data are from
four independent experiments; shControl (429 cells from 22 movies), shDLC1
3′UTR (236 cells from 12 movies), shDLC1 #1063 (303 cells from 18 movies)
***P<0.001 (one-way ANOVA and Dunnett’s multiple comparison test).
(F) Widefield immunofluorescence images of HUVECs transduced with
shControl, shDLC1 3′UTR or shDLC1 #1063 6 h after initiation of scratch
wound assays stained for DAPI (blue), GM130 (red; Golgi) and VE-cadherin
(green). Cells were considered polarized if the Golgi was located within an
angle between 60° and −60° towards the migration front. The yellow dashed
lines indicate the migration front and the asterisks indicate cells containing an
oriented Golgi in the direction of scratch wound migration. Box-plot showing
themedian (and upper and lower quartiles) of cells with an oriented Golgi. Data
are from three independent experiments; shControl (34 images), shDLC1 3′
UTR (30 images), shDLC1 #1063 (35 images). ***P<0.001 (one-way ANOVA
with Dunnett’s multiple comparison test). (G) Representative fluorescence
images of HUVECs transduced with shControl-RFP or shDLC1 3′UTR and
subsequently with GFP in a scratch wound assay (t=0 and t=12 h after
scratch). The yellow dashed line highlights the migration front. Graph shows
the proportion of shControl RFP or shDLC1 GFP cells at the leading edge at
t=0 and t=12 h after scratch. Data are from three independent experiments;
shControl RFP (24 movies), shDLC1 3′UTR GFP (24 movies). ***P<0.001;
n.s., not significant (one-way ANOVA with Dunnett’s multiple comparisons
test). (H) Widefield immunofluorescence images of HUVECs transduced with
shControl, shDLC1 3′UTR or shDLC1 #1063 6 h after initiation of scratch
wound assays stained for vinculin (red), F-actin (blue) and VE-cadherin
(green). Boxplots show the median (and upper and lower quartiles) focal
adhesion alignment index and focal adhesion dominant angle as determined
by image analysis of the vinculin channels using the focal adhesion analysis
server (Berginski and Gomez, 2013). Whiskers show the range. Data are from
three independent experiments; shControl (34 images), shDLC1 3′UTR (15
images), shDLC1 #1063 (36 images). *P<0.05, **P<0.01; n.s., not significant
(one-way ANOVA with Dunnett’s multiple comparison test).
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blood vessel integrity through suppression of DLC1-driven
endothelial migration and/or angiogenic sprouting.
Disturbed crosstalk between DLC1 and YAP/TAZ in
pathology?
DLC1 expression is elevated in the endothelium of atherosclerotic
plaques and in pulmonary hypertension (Schimmel et al., 2018).
The development of these cardiovascular diseases is driven by
pathological stiffening and disturbed flow patterns (Huveneers
et al., 2015), which activate endothelial YAP/TAZ (Wang et al.,
2016a,b; Bertero et al., 2016). Therefore, targeting of YAP/TAZ, or
their downstream targets such as DLC1, holds promise as
therapeutic approach in stiffness-related vascular diseases. Of
interest, mutations in the YAP and TAZ genes (Antonescu, 2014)
Fig. 4. DLC1 controls sprouting angiogenesis. (A) Representative phase-contrast images of sprouting spheroids 16 h after VEGF stimulation of HUVECs
lentivirally transduced with shControl or shDLC1 (pool of #1063 and #1064). Box-plot shows the median (and upper and lower quartiles) cumulative sprout length
and the number of sprouts in the spheroid-based sprouting angiogenesis assays. Whiskers show the range. Data are from thee independent experiments;
shControl (63 spheroids), shDLC1 (47 spheroids). ***P<0.001 (two-tailed unpaired Student’s t-test). (B) Representative phase-contrast images of sprouting
spheroids 16 h after VEGF stimulation of HUVECs lentivirally transduced with GFP or GFP–DLC1. Box-plot shows the median (and upper and lower quartiles)
cumulative sprout length and the number of sprouts in the spheroid-based sprouting angiogenesis assays. Whiskers show the range. Data are from three
independent experiments; GFP (25 spheroids), GFP–DLC1 (27 spheroids). ***P<0.001 (two-tailed unpaired Student’s t-test). (C) Representative phase-contrast
images of sprouting spheroids 16 h after VEGF stimulation of HUVECs transduced with shControl or shDLC1 3′UTR and rescued with GFP or GFP-DLC1. Box-
plots show the median (and upper and lower quartiles) cumulative sprout length and number of sprouts per spheroid. Whiskers show the range. Data are from
three independent experiments, shControl (33 spheroids), shDLC1 3′UTR (29 spheroids), rescueGFP (39 spheroids), rescueGFP-DLC1 (37 spheroids). n.s., not
significant; *P<0.05; ***P<0.001 (one-way ANOVA with Dunnett’s multiple comparisons test). In A–C, smaller images underneath main phase-contrast images
show the overlaid quantified sprouts in yellow. (D) Representative western blot analysis of DLC1, GFP and α-tubulin (loading control) in lysates of HUVECs
transduced with shControl or shDLC1 3′UTR and rescued with GFP or GFP–DLC1. Note that the GFP-tagged DLC1 has a higher molecular mass than
endogenous DLC1. Scans of whole western blots are depicted in Fig. S4.
9

















correlate with loss of DLC1 expression in hemangioendotheliomas
and angiosarcomas (Sánchez-Martín et al., 2018; Ha et al., 2018),
two (rare) types of endothelial malignancies that are characterized
by uncontrolled proliferation and infiltration of endothelial cells. A
recent study further suggests that DLC1 deficiency is an upstream
inducer of YAP/TAZ signaling in endothelial malignancies
Fig. 5. See next page for legend.
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(Ritchey et al., 2019). This would fit with a model in which YAP/
TAZ and DLC1 control each other via feedbackmechanisms that are
sensed at focal adhesions. Because DLC1 is expressed in many cell
types beyond the endothelium, and because DLC1 has been
identified as a tumor suppressor in various types of cancer (Liao and
Lo, 2008; Durkin et al., 2007), we postulate that DLC1 might also
function in YAP/TAZ-driven cancer cell behavior, and other




Purified mouse anti-human DLC1 [Clone 3, Cat# 612021, diluted 1:1000
for western blotting (WB)] and purified mouse anti-GM130 [clone 35, Cat#
610823, diluted 1:200 for immunofluorescence (IF)] were obtained from
BD Biosciences. To visualize VE-cadherin we used purified mouse anti-
cadherin-5 (BD Biosciences, clone 75, Cat# 610252, diluted 1:100 for IF)
and rabbit polyclonal anti-VE-cadherin (Cayman Chemical, Cat # 160840,
diluted 1:100 for IF). Rabbit polyclonal anti-phospho-paxillin (Tyr118)
(Cat# 44-722G, diluted 1:200 for IF) was from Thermo Fischer Scientific.
Mouse monoclonal anti-vinculin (hVIN-1 clone, Cat# V9131, diluted 1:400
for IF) and rabbit polyclonal anti-WWTR1 (anti-TAZ, Cat# HPA007415,
diluted 1:1000 for WB) were obtained from Sigma-Aldrich. We used rabbit
polyclonal anti-YAP1 (Genetex, Cat# GTX129151, diluted 1:1000 for WB)
to detect YAP, mouse monoclonal anti-c-Myc (clone 9E10, Cat# SC-40,
diluted 1:1000 for WB) and goat polyclonal anti CTGF (Santa Cruz
Biotechnology, L-20, Cat # sc-14939, diluted 1:1000 for WB) to detect
CTGF. To detect GFP we used the monoclonal mouse anti-GFP antibody
(Santa Cruz Biotechnology, B-2, Cat # sc-9996, 1:1000 for WB). As a
loading control, we stained with mouse monoclonal anti-human α-tubulin
(Cedarlane, Clone DM1A, Cat# CLT9002, diluted 1:10,000 for WB) or
rabbit polyclonal anti-β-actin (Cell Signaling, Cat# 4967S, diluted 1:1000
for WB). Secondary antibodies coupled to Alexa Fluor 488, 594 and 647,
were purchased from Invitrogen (diluted 1:100 for IF). To visualize F-actin
we used PromoFluor-415–phalloidin (Promokine, Cat# PK-PF415-7-01,
diluted 1:200 for IF), Alexa Fluor 568–phalloidin (Thermo Fisher
Scientific, Cat# A12380, diluted 1:200 for IF) or Texas Red–X Phalloidin
(Thermo Fisher, Cat# T7471, diluted 1:200 for IF). DAPI was used for
nuclear immunofluorescence stainings (Invitrogen, diluted 1:1000).
Secondary antibodies coupled to horseradish peroxidase (HRP) were
obtained from Bio-Rad (diluted 1:1000 for WB). Thrombin (used at
0.2 U/ml) was from Haematologic Technologies. Doxycyclin (used at
1 ng/ml) was from Sigma-Aldrich.
Cell culture
Pooled primary HUVECs (cultured up to passage six) from different
donors (Lonza) were cultured in Endothelial Cell Growth Medium 2
culture medium supplemented with the Growth Medium 2 Supplement
Pack (PromoCell) on gelatin-coated tissue flasks. 2 kPa or 50 kPa
hydrogels (Matrigen) were activated with PBS and coated with
5 µg ml−1 fibronectin overnight. HEK293T cells (ATCC) were cultured
in Dulbecco’s modified Eagle’s medium with L-glutamine supplemented
with 10% fetal bovine serum and antibiotics. Cells were recently
authenticated and tested for contamination.
DNA plasmids and lentiviral transductions
shRNAs in the lentiviral pLKO.1 backbone targeting DLC1 (TRCN47823,
47824, 47825, 47826 and 47827, which in this manuscript are referred to as
plasmid numbers #1063, #1064, #1065, #1066 and #1067 respectively),
YAP1 (TRCN107265), TAZ (TRCN19473) and control shRNA (shC002)
with or without tagRFP were from Sigma-Aldrich mission library.
A modified version of the pLKO.1 plasmid was generated based on the
5′-GGAGTGTAGGAATTGACTATA-3′ sequence to express shRNA that
target the 3′-UTR of human DLC1 mRNA. Full-length human DLC1 fused
at its N-terminus to a GFP tag was amplified by PCR from a pEGFP-C1-
DLC1 vector (provided by Xiaolan Qian and Douglas Lowy, NIH,
Bethesda, MD) and cloned into a self-inactivating lentiviral pLV-CMV-
ires-puro vector between the SnaBI and XbaI restriction sites. For the
pInducer20-myc-hYAP1-5SA-Ubc construct, human YAP1 with S61A,
S109A, S127A, S164A, S381A mutations was amplified by PCR from a
pQCXIH vector (Zhao et al., 2007) and through Gateway Recombination
cloned into a pInducer20 vector with Ubc promoter (Meerbrey et al., 2011).
The pRRL paxillin-mCherry construct was a gift from Olivier Pertz
(University of Basel, Switzerland) and pLenti-GFP from Johan de
Rooij (UMC Utrecht, The Netherlands). Luciferase reporter constructs
are based on a pGL3 basic luciferase reporter vector (Promega),
containing a firefly luciferase gene. The DLC1 promoter region (−418
to +319 bp from the transcriptional start site) containing the wild-type
TEAD motif (CATTCCA) or a mutated motif (AGACTAT) were
purchased from GenScript and inserted at the 5′ end of the luciferase
gene between NheI and BglII restriction sites. To produce lentiviral
particles, HEK293T cells were transfected with third-generation
packaging constructs and lentiviral expression vectors using Trans-IT-
LTI transfection reagents (Mirus). Lentivirus containing supernatant was
harvested 48–72 h post transfection. HUVECs, cultured up to ∼80%
confluency, were transduced with lentiviral particles overnight. shRNA-
based knockdown cells were analyzed at least 48 h after transduction. For
TIRF microscopy, HUVECs were first transduced with shDLC1 or
shControl lentivirus, and subsequently transduced with paxillin–mCherry
lentivirus. Expression of YAP-5SA was induced by doxycyclin treatment
for 48 h.
Electric cell-substrate impedance sensing
ECIS was used to analyze endothelial barrier function. Electrode arrays
(8W10E; IBIDI) were treated with 10 mM L-cysteine (Sigma-Aldrich) for
15 min at 37°C. After washing with 0.9% NaCl, the arrays were coated with
10 µg ml−1 fibronectin in 0.9% NaCl for 1 h at 37°C. Cells were seeded on
the arrays and the impedance was measured during monolayer formation at
4 kHz using the ECIS model ZTheta (Applied BioPhysics).
G-LISA – RhoA activity assays
For analysis of RhoA activity, confluent HUVECs were washed with ice-
cold PBS and lysed in lysis buffer from the RhoA G-LISA activation kit
(Cytoskeleton). RhoA activity was determined according to manufacturer’s
protocol.
Immunofluorescence stainings
For standard immunofluorescence stainings, cells were cultured on
coverslips coated with 5 µg ml−1 fibronectin. Cells were fixed by 10 min
Fig. 5. DLC1 rescues the migration and sprouting defects in YAP-depleted
endothelial cells. (A) Phase-contrast images of HUVECs transduced with
shControl or shYAP and rescued with GFP or GFP–DLC1, in a scratch-wound
assay (t=0, t=4, t=8 and t=12 h after scratch). The yellow line highlights the
unclosed wound area. (B) Graph showing the mean±s.e.m. percentage of
wound closure of HUVECs transduced with shControl or shYAP and rescued
with GFP or GFP–DLC1 at three time-points during the scratch-wound assay.
Data are from three independent experiments; shControl (14 movies), shYAP
(14 movies), rescue GFP (11 movies), rescue GFP–DLC1 (7 movies). *P<0.05;
***P<0.001; n.s., not significant (one-way ANOVA with Dunnett’s multiple
comparisons test). (C) Western blot analysis of DLC1, YAP, GFP and β-actin in
lysates of HUVECs transduced with shControl, shYAP and rescued with GFP or
GFP–DLC1. Scans of whole western blots are depicted in Fig. S4.
(D) Representativewidefield IF images ofHUVECs transducedwith shControl or
shYAP, or shYAP-transducedHUVECsexpressingGFPorGFP-DLC1, 6 h after
initiation of scratch wound assay. Stained for Vinculin (red) and F-actin (green).
The asterisks indicate the GFP-positive cells (not shown). (E) Representative
phase-contrast images of sprouting spheroids 16 h after VEGF stimulation of
HUVECs transduced with shControl, shYAP and rescued with GFP or GFP–
DLC1. Smaller images underneath main phase-contrast images show the
overlaid quantified sprouts in yellow. Box-plots show the median (and upper and
lower quartiles) cumulative sprout length and number of sprouts per spheroid.
Whiskers show the range. Data are from three independent experiments;
shControl (27 spheroids), shYAP (18 spheroids), rescue GFP (21 spheroids),
rescue GFP-DLC1 (28 spheroids). *P<0.05, ***P<0.001; n.s., not significant
(one-way ANOVA with Dunnett’s multiple comparison test).
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incubation with 4% paraformaldehyde in PBS++ (PBS with 1 mM CaCl2
and 0.5 mM MgCl2). Fixed cells were permeabilized for 5 min with 0.5%
Triton X-100 in PBS and blocked for 30 min in 2% BSA in PBS. Primary
and secondary antibodies were diluted in 0.5% BSA in PBS and incubated
for 45 min. After each step, the fixed cells were washed three times with
0.5% BSA in PBS. Coverslips were mounted in Mowiol4-88/DABCO
solution.
Luciferase assays
HEK293 cells were seeded sparsely (75,000 cells per well) in 24-wells
plates coated with gelatin. Cells were transfected with the pGL3-DLC1-
promoter luciferase reporter plasmids using PEI (Polysciences). pRL-TK
Renilla reporter plasmid was co-transfected (1:50) as a control for transfection
efficiency. At 2 days after transfection firefly and Renilla luciferase activities
were analyzed using the Dual-Luciferase Reporter Assay System (Promega)
and the GloMax-Multi detection system (Promega) according tomanufacturer’s
protocol.
Quantitative PCR
Total RNAwas isolated from HUVECs using TRI Reagent (Sigma). cDNA
synthesis was performed using iScript (Bio-Rad). Quantitative polymerase
chain reaction was performed using SensiFAST SYBR Green No-ROX
(Bioline) on a LightCycler 480 system (Roche). To calculate the relative
gene expression, the ΔΔCt method was used. DLC1 expression was
corrected for RPLP0 reference expression, and DLC1 expression levels were
normalized to its levels on plastic. Primer sequences were as follows: DLC1
forward 5′-ATGATCGCCGAGTGCAAGAA-3′ and reverse 5′-CTGCT-
CCGAAGTGGAGTAGC-3′. RPLP0 forward 5′-TCGACAATGGCAGC-
ATCTAC-3′ and reverse 5′-ATCCGTCTCCACAGACAAGG-3′.
Scratch assays
For scratch assays, HUVECs were plated on 12-well or 24-well plates
coated with 5 µg ml−1 fibronectin. Two perpendicular scratches per well
were made using a sterile 200 µl pipette tip. Next, cells were washed with
PBS++, cultured in EGM-2 medium, and were mounted on an inverted
NIKON Eclipse TI microscope equipped with an Okolab cage incubator
and humidified CO2 gas chamber set to 37°C and 5% CO2. Cells were
live imaged (for 16–20 h; 10 min time interval) using phase-contrast
imaging using a 10× CFI Achromat DL dry objective (NA 0.25) and an
Andor Zyla 4.2 plus sCMOS camera. Images were enhanced for display
with an unsharp mask filter and adjusted for brightness and contrast in
ImageJ. Scratch wounding surface was quantified by measuring the
wound area using the freehand tool in ImageJ. The ImageJ manual
tracking plugin was used for single-cell tracking, and the Chemotaxis
tool was used to quantify directionality and velocity. For
immunofluorescence stainings of scratch assays, cells were plated on
coverslips coated with 5 µg ml−1 fibronectin and fixed after 6 h with 4%
PFA. Golgi orientation was assessed by measuring the center of mass of
the DAPI and GM130 signal and calculating the angle between these
points in relation to the direction of migration. Focal adhesion orientation
was analyzed using the focal adhesion server using a minimal adhesion
size of 4 pixels and a maximal adhesion size of 115 pixels (Berginski
and Gomez, 2013).
Sprouting angiogenesis assays
For sprouting angiogenesis assays, HUVECs were resuspended in EGM-2
medium containing 0.1% methylcellulose (4000 cP, Sigma). For spheroid
formation, 750 cells per 100 µl methylcellulose medium were seeded in
wells of a U-bottom 96-wells plate and incubated overnight. Spheroids were
collected and resuspended in 1.7 mg/ml collagen type I rat tail mixture
(IBIDI), plated in glass-bottom 96-well plates and placed at 37°C. After
polymerization of the collagen gel, spheroids were stimulated with
50 ng ml−1 VEGF to induce sprouting overnight as described previously
(Korff and Augustin, 1999). Pictures were taken using the EVOS M7000
imaging system and a 10× objective. Images were enhanced for display with
an unsharp mask filter and adjusted for brightness and contrast in ImageJ.
Sprouting number and length was analyzed using the ImageJ plugin
NeuronJ.
Fluorescence microscopy
For live-cell fluorescence microscopy, cells were plated on Lab-Tek
chambered 1.0 borosilicated coverglass slides coated with 5 µg ml−1
fibronectin and cultured in EGM2 culture medium. For TIRF microscopy,
we used an inverted NIKON Eclipse TI equipped with a 60×1.49 NA Apo
TIRF (oil) objective, perfect focus system, Orange Diode Solid State Laser
594 nm 30 mW (Excelsior, Spectra-physics), dual band 488/594 nm TIRF
filter cube (Chroma TRF59905 ET), and an Andor Zyla 4.2 plus sCMOS
camera (without binning). An Okolab cage incubator and humidified CO2
gas chamber set to 37°C and 5%CO2were used during the imaging process.
Image acquisition was performed every 30 s interval for 3–5 h. To analyze
focal adhesion dynamics, the raw data was uploaded to the focal adhesion
server using a minimal adhesion size of 4 pixels and phase length of 5 min
(Berginski and Gomez, 2013). For widefield microscopy of immunostained
HUVECs, the NIKONEclipse TI was equipped with a lumencor SOLA SE II
light source and standard DAPI, GFP, mCherry or Cy5 filter cubes (NIKON).
Samples stained for immunofluorescence in Fig. 2B,F were imaged using
an inverted Zeiss widefield microscopes Observer.Z1 equipped with a
63×1.40 Plan Apochromat oil objective and a Hamamatsu Orca-R2 digital
camera. Images were enhanced for display with an unsharp mask filter and
adjusted for brightness and contrast in ImageJ.
Traction force microscopy
For traction force microscopy, HUVECS were plated on collagen-coated
1.2 kPa (Young’s modulus) polyacrylamide substrates containing 2 µm
reference bottom beads and 0.2 µm sulfated top beads (FluoSpheres,
Molecular Probes). HUVECS were cultured to confluency on the gels for
48 h, and subsequently visualized using an inverted Zeiss Axiovert 200
widefield microscope equipped with a 40×0.75 NA Zeiss air objective,
Cooke Sensicam CCD camera and IBIDI climate-control system. To
determine traction forces, the top and reference beads were imaged using
fluorescence microscopy and DIC to visualize the HUVECs. Finally, the
HUVECs were trypsinized from the substrate to acquire images of the
unloaded fiducial bead patterns. Computation of traction forces was
performed as described previously using known material properties
(stiffness=1.2 kPa, Poisson’s ratio=0.48) and the constrained two-
dimensional fast Fourier transformation method (Valent et al., 2016).
From the monolayer traction fields, the root mean squared value of traction
in pascals was calculated as scalar measure for monolayer traction.
Western blot analysis
Cells were lysed with reduced sample buffer containing 4% β-
mercaptoethanol. Samples were boiled at 95° for 5–10 min to denature
the proteins. 10% SDS-PAGE gels were used in SDS-page running buffer
(25 mM Tris-HCl pH 8.3, 192 mM glycine and 0.1% SDS), and transferred
to ethanol-activated PVDF membrane using wet transfer in blot buffer
[25 mM Tris-HCl pH 8.3, 192 mM glycine and 20% (v/v) ethanol]. Blots
were blocked with 5%milk powder or BSA in Tris-buffered saline (TBS) for
30 min. Blots were incubated overnight at 4°C with the primary antibodies
in 5% milk/BSA in TBS with Tween-20 (TBST). The secondary antibodies
linked to horseradish peroxidase (HRP) were incubated with the membrane
for 45 min at room temperature. As final step before imaging, blots were
washed with TBS. HRP signals were visualized by enhanced
chemiluminescence (ECL) detection (SuperSignal West Pico PLUS,
Thermo Fisher, Cat # 34580) and visualized with a ImageQuant LAS
4000 (GE Healthcare) machine. Intensities of bands were quantified by
using the Gel Analyzer plugin in ImageJ.
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Table S1. GEO accession numbers for data analyzed in this study 
TEAD1 – muscle : GSM1331246 (RD HUMAN TEAD-CHIPSEQ _48240-treat) 
TEAD1 – astrocyte : GSM1515741 (TEAD1-SF268_REP1_54611_treat) 
TEAD1 – lung : GSM1664955 (MSTO TEAD1_56535_treat) 
TEAD1 – carcinoma : GSM11667161 (HUCCT1 TEAD1_56542_Treat) 
H3K4me1 (HUVEC) – GSM733690 (BERNSTEIN_HUVEC_H3K4ME1_45367_treat) 
H3K4me3 (HUVEC) – GSM733673 (BERNSTEIN_HUVEC_H3K4ME3_45376_treat) 
H3K27ac (HUVEC) – GSM733691 (BERNSTEIN_HUVEC_H3K27AC_45360_treat) 
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Supplemental Figure 1
Figure S1. Full detailed schematics of UCSC genome browser results at position 
chr8:13,074,715-13,142,890 of the human genome (GRCh38/hg38) showing the genomic 
location of DLC1 transcript variants 1 (NP_872584.2), 2 (NP_006085.2), 5 (NP_001303597.1) 
and 4 (NP_001157743.1) and the presence of a TEAD motif at the transcriptional start site 
(TSS) of DLC1 transcript variant 2. Plotted are the results from publicly available GEO 
data TEAD1 ChIP-Seq data from various cell types and corresponding histone modification 
profiles in HUVECs in ENCODE. The data show a binding peak of TEAD1 at the TSS of DLC1 
transcript variant 2. Histone modification profiles indicate that there is an open 
conformation of chromatin and an active promoter region around the TEAD binding 
motif, defined as the bimodal presence of both histone H3 trimethylation at lysine 4 
(H3K4me3) and histone H3 acetylation at lysine 27 (H3K27ac), combined with increased 
DNase hypersensitivity. 
Figure S2. Full scans of Western experiments in Figure 1. Molecular weights of the marker, 
exposure times, sensitive scanning mode and following order of antibody probing are 
indicated. 















































































































































































































































Figure S2. Full scans of Western experiments in Figure 1. Molecular weights of the marker, 
exposure times, sensitive scanning mode and following order of antibody probing are 
indicated. 
































































Figure S3. Widefield IF images of HUVECs fixed 6 hours after initiation of scratch wound 
assays stained for DAPI (blue), F-actin (green) and YAP (red). Pictures taken of the 
follower cells in the center of the monolayer and of the leader cells at the scratch wound 
edge. Asterisks highlight cells with nuclear enrichment of YAP compared to the cytoplasm. 




























































































































































Figure S4. Full scans of Western experiments in Figure 3-5. Molecular weights of the 
marker, exposure times, sensitive scanning mode and following order of antibody 
probing are indicated. 



































Movie 1. DLC1 controls endothelial focal adhesion dynamics. Time lapse recording of 
HUVECs transduced with shControl or shDLC1 and expressing paxillin-mCherry. Images 
were acquired by time-lapse TIRF microscopy (NIKON Eclipse Ti) using a 60x/1.49 NA oil 
objective. Frames were taken every 30 sec for ~ 2,5 hours. 
Movie 2. DLC1 is needed for endothelial directional migration. Time lapse recording of 
HUVECs transduced with shControl, shDLC1 3’UTR or shDLC1 #1063 during scratch 
wound migration. Images were acquired by time-lapse phase-contrast microscopy 
(NIKON Eclipse Ti) using a 10x dry objective. Frames were taken every 10 min for ~ 16 hours. 



































Movie 3. DLC1 is needed to establish leader cells during directional migration. Time lapse 
recording of mosaic cultures of HUVECs transduced with shControl (RFP) or shDLC1 (GFP) 
during scratch wound migration. Images were acquired by time-lapse fluorescence 
microscopy (NIKON Eclipse Ti) using a 20x/0.75 NA dry objective. Frames were taken every 10 
min for ~ 17 hours.  
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